According to recent research by Fujii [23], serum albumin is also superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer, which is an interesting theme needed to be investigated in our FTMDT trial after long-time follow-up. Here, ALB is linked to colorectal cancer.